期刊文献+

磺丁基醚-β-环糊精对桂利嗪的包合作用 被引量:2

Utilization of sulfobutyl ether-β-cyclodextrin as the solubilizer of cinnarizine
下载PDF
导出
摘要 目的通过研究磺丁基醚-β-环糊精对桂利嗪增溶作用,包合物的制备以及包合物光谱学结构确证来研究磺丁基醚-β-环糊精对桂利嗪的包合作用。方法在25℃运用相溶解度法进行实验,采用紫外分光光度法测定桂利嗪在溶液中的浓度;采用冷冻干燥法来制备磺丁基醚-β-环糊精桂利嗪包合物,再使用DSC和X-射线衍射法来进行结构确证。结果随着磺丁基醚-β-环糊精浓度增加和pH值减小,桂利嗪的溶解度显著提高;采用冷冻干燥法制备包合物时,桂利嗪被完全包入磺丁基醚-β-环糊精孔穴内部。结论磺丁基醚-β-环糊精可提高难溶性药物桂利嗪的溶解度并能形成稳定的包合物。 Objective To study the clathration of ether-β-cyclodextrin(SBE-β-CD)with cinnarizine through solution effects,complexes preparation and structure identification by spectrum method.Methods The solubilization experiment was performed by the phase-solubility method at 25 ℃.The concentration of cinnarizine was determined by the UV spectrophotometric method.Freeze drying method was used in the preparation of complexes and the complexes were verified using DSC and X-ray diffraction.Results The apparent solubility of cinnarizine was enhanced obviously with the increase of concentration SBE-β-CD and decrease of pH values.The apparent stability constants were calculated respectively.Conclusions SBE-β-CD is a good solubilizer for cinnarizine and can form stable complexes with it.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第7期520-524,共5页 Journal of Shenyang Pharmaceutical University
关键词 磺丁基醚-Β-环糊精 桂利嗪 溶解度 包合物 sulfobutyl ether-β-cyclodextrin cinnarizine solubility inclusion complex
  • 相关文献

参考文献6

  • 1TOMI J, KRISTIINA J, NANCY S, et al.β-cyclodextrin derivatives, SBE4-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs [ J ]. J Pharm Sci, 1995,84 ( 3 ) :295 - 299.
  • 2王建华,宋爱晶.一种新型辅料磺丁基醚-β-环糊精的药学应用进展[J].材料导报,2007,21(3):40-43. 被引量:27
  • 3OKIMOTO K,TOKUNAGA Y J, IBUKI R, et al. Applicability of(SBE) 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs) [ J ]. Int J Pharmaceutics, 2004,286:81 - 88.
  • 4TOKUMURA T. Preparation of cinnarizine/β-cyclodextrin inclution complex by spray-drying method and the stability of complex in solid state[J]. Yakuzaigaku, 1985,45 ( 1 ) : 1 - 6.
  • 5BREWSTER M E, SIMPKINS J W, HORA M S, et al. The potential use of cyclodextrins in parenteral formulations [ J ]. J Parent Sci Tech, 1989,43 ( 5 ) : 231 - 240.
  • 6施洁明,何仲贵,刘晓红,孙英华,李鸿滨,施其海.2-羟丙基-β-环糊精对桂利嗪的增溶作用[J].中国新药杂志,2004,13(3):233-235. 被引量:10

二级参考文献38

  • 1代国飞,王明伟.环糊精及其衍生物的药学应用进展[J].中国新药杂志,2005,14(11):1261-1264. 被引量:23
  • 2Brewster ME, Simpkins JW, Hora MS, et al. The potential use of cyclodextrins in parenteral formulations [J]. J Parent Sci Tech,1989,43(5) :231 - 240.
  • 3Paola M, Faucci MT,Gian PB. The influencee of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin [J]. Eur J Pharm Sci,2001,13(2) : 187 - 194.
  • 4毕殿洲.药剂学[M].第4版[M].北京:人民卫生出版社,1999.272.
  • 5Brewster ME,Simpkins JW,Hora MS,et al.The potential use of cyclodextrins in parenteral formulations[J].J Parent Sci Tech,1989,43(5):231-240.
  • 6Paola M,Faucci MT,Gian PB.The influencee of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin[J].Eur J Pharm Sci,2001,13(2):187-194.
  • 7Zhao L W,Li P,Samuel H Y.Solubilization of fluasterone[J].J Pharmaceutical Sci,1999,88(10):967
  • 8Okimoto K,Tokunaga Y J,Ibuki R,et al.Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)[J].Int J Pharmaceutics,2004,286:81
  • 9Rao V M,Haslam J L,Stella V J.Controlled and complete release of a model poorly water-soluble drug,prednisolone,from hydroxypropyl methylcellulose matrix tablets using (SBE)7m-β-CD as a solubilizing agent[J].J Pharmaceutical Sci,2001,90(7):807
  • 10Rajewski R A,Stella V J.Pharmaceutical applications of cyclodextrins.2.in vivo drug delivery[J].J Pharmaceutical Sci,1996,85(11):1142

共引文献34

同被引文献19

  • 1谷福根,高永良,崔福德.环糊精包合物研究进展[J].中国新药杂志,2005,14(6):686-693. 被引量:47
  • 2李丽杰,王洪光.环糊精包合技术对伊曲康唑的增溶[J].青岛科技大学学报(自然科学版),2007,28(1):16-19. 被引量:3
  • 3王建华,宋爱晶.一种新型辅料磺丁基醚-β-环糊精的药学应用进展[J].材料导报,2007,21(3):40-43. 被引量:27
  • 4Aburuz S, Millership J, Mcelnay J. The development and validation of liquid chromatography method for the simul- taneous determination of metformin and glipizide, gliclaz- ide, glibenclamide or glimperide in plasma[ J ]. J Chroma- togr B Analy Technol Biomed Life Sci ,2005,817 (2) :277 - 286.
  • 5Okimoto K, Tokunaga Y, Ibuki R, et al. Applicability of (SBE) 7m- beta- CD in controlled- porosity osmotic pump tablets (OPTs) [ J ]. Int J Pharm, 2004,286 ( 1 - 2) :81 -88.
  • 6Gbaribzahedi SM, Razavi SH, Mousavi M. Characterizing the natural eanthaxanthin/2 - bydroxypropyl - 13 - cyclo- dextrin inclusion complex [ J 1. Carbohydr Polym, 2014, 101:1147 - 1153.
  • 7Tokumura T. Preparation of cinnarizine/13 - eycldextrin in- clusion complex by spray -drying method and the stability of complex in solid state [ J ]. Yakuzaigaku, 1985,45 : 1 - 6.
  • 8SCHILLER D S,FUNG H B.Posaconazole:an extended-spectrum triazole antifungal agent[J].Clin Ther,2007,29(9):1862-1886.
  • 9HIGUCHI T,CONNORS K A.Phase solubility techniques[J].Adv Anal Chem Instr,1965,4:117-212.
  • 10刘恒平.伊曲康唑包合物的制备与研究[J].中国生化药物杂志,2008,29(3):182-185. 被引量:4

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部